Literature DB >> 25624408

First reported Australian case of Cladophilophora arxii: features consistent with possible primary pulmonary chromoblastomycosis.

Anna Brischetto1, Sarah Kidd2, Rob Baird2.   

Abstract

We describe the first case of possible pulmonary chromoblastomycosis in the absence of any identified cutaneous lesions in a relatively immunosuppressed man. The causative organism was Cladophialophora arxii, which is a rare pathogen that has only been described as causing human disease two times previously. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25624408      PMCID: PMC4385774          DOI: 10.4269/ajtmh.14-0711

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Corneal chromoblastomycosis caused by Cladophialophora carrionii after cataract surgery.

Authors:  Hamed Bazargan Lari; Neena Mirani; David S Chu
Journal:  J Cataract Refract Surg       Date:  2011-05       Impact factor: 3.351

2.  An autopsy case of primary chromoblastomycosis arising from the internal organs. Dark-brown granulomas in the liver and the brain without skin symptoms, observed in a smoking child 3 years old.

Authors:  N SASANO; T OKAMOTO; T TAKAHASHI; S SUZUKI
Journal:  Tohoku J Exp Med       Date:  1961-01-25       Impact factor: 1.848

Review 3.  Chromoblastomycosis.

Authors:  Rubén López Martínez; Luis Javier Méndez Tovar
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

4.  Chromoblastomycosis in India.

Authors:  N L Sharma; R C Sharma; P S Grover; M L Gupta; A K Sharma; V K Mahajan
Journal:  Int J Dermatol       Date:  1999-11       Impact factor: 2.736

5.  Chromoblastomycosis caused by Cladosporium trichoides and associated pulmonary involvement and case report.

Authors:  D M Owili; H Nsanzumuhire; W Ngare
Journal:  East Afr Med J       Date:  1982-03

6.  Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease.

Authors:  T Shigemura; K Agematsu; T Yamazaki; K Eriko; G Yasuda; K Nishimura; K Koike
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

7.  Chromoblastomycosis in Australia: an historical perspective.

Authors:  David Weedon; Mitchell van Deurse; Scott Allison; Cliff Rosendahl
Journal:  Pathology       Date:  2013-08       Impact factor: 5.306

Review 8.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 9.  Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.

Authors:  Flavio Queiroz-Telles; Phillippe Esterre; Maigualida Perez-Blanco; Roxana G Vitale; Claudio Guedes Salgado; Alexandro Bonifaz
Journal:  Med Mycol       Date:  2008-12-09       Impact factor: 4.076

10.  Systemic mycosis caused by a new Cladophialophora species.

Authors:  K Tintelnot; P von Hunnius; G S de Hoog; A Polak-Wyss; E Guého; F Masclaux
Journal:  J Med Vet Mycol       Date:  1995 Sep-Oct
View more
  2 in total

1.  Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.

Authors:  S Deng; W Lei; G S de Hoog; L Yang; R G Vitale; H Rafati; M Seyedmousavi; A Tolooe; H van der Lee; W Liao; P E Verweij; S Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 2.  Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.

Authors:  Luiz Felipe Domingues Passero; Italo Novais Cavallone; Walter Belda
Journal:  J Immunol Res       Date:  2021-11-01       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.